The origin of spermatozoa does not affect intracytoplasmic sperm injection outcome

Eur J Obstet Gynecol Reprod Biol. 2001 Feb;94(2):250-5. doi: 10.1016/s0301-2115(00)00347-x.

Abstract

Objective: To assess whether the origin of spermatozoa, ejaculate or testicular, affects intracytoplasmic sperm injection (ICSI) outcome.

Study design: Retrospective study of 890 consecutive first ICSI and embryo transfer cycles done for male infertility. The ICSI outcome of ejaculated spermatozoa (n=780) and testicular spermatozoa retrieved from patients with obstructive azoospermia (n=43), non-obstructive azoospermia (n=53) and severe oligoasthenoteratozoospermia (n=14) were compared by using chi-square test, independent t-test and ANOVA with Bonferroni test.

Results: All azoospermic males had a diagnostic testicular biopsy at least 6 months before the ICSI procedure. Spermatozoa were successfully retrieved in all 43 patients with obstructive azoospermia and in 72.6% of 73 non-obstructive cases. The cycle characteristics of the four groups were similar apart from a younger mean female age in the non-obstructive azoospermia group when compared with the ejaculated spermatozoa group. The fertilization, implantation and clinical pregnancy rates were comparable among the four groups.

Conclusion: Testicular spermatozoa recovered from patients with obstructive and all types of non-obstructive azoospermia were as much as effective as ejaculated spermatozoa in ICSI.

MeSH terms

  • 17 alpha-Hydroxyprogesterone Caproate
  • Ejaculation
  • Embryo Implantation
  • Embryo Transfer
  • Female
  • Humans
  • Hydroxyprogesterones / administration & dosage
  • Infertility, Male / therapy*
  • Male
  • Oligospermia / therapy
  • Pregnancy
  • Specimen Handling / methods
  • Sperm Injections, Intracytoplasmic*
  • Spermatozoa*
  • Testis / cytology*
  • Treatment Outcome*

Substances

  • Hydroxyprogesterones
  • 17 alpha-Hydroxyprogesterone Caproate